Grace Therapeutics, Inc. (GRCE) — Dilution Risk Analysis
Current Snapshot
Grace Therapeutics, Inc. (GRCE) has a DilutionWatch score of 52/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 52/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 4 9, FORM 4 1.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-10-01 | 0001493152-26-045358 |
| 4 | 2026-09-23 | 0001493152-26-043996 |
| 4 | 2026-09-21 | 0001140361-26-037237 |
| 4 | 2026-09-21 | 0001140361-26-037239 |
| 4 | 2026-09-21 | 0001140361-26-037245 |
| 4 | 2026-09-21 | 0001140361-26-037246 |
| 4 | 2026-09-10 | 0001140361-26-036125 |
| 4 | 2026-09-10 | 0001493152-26-042152 |
| Form 4 | 2026-09-09 | 0001140361-26-036125|0001946739|2026-09-09|P|100000 |
| 4 | 2026-09-01 | 0001140361-26-035316 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 11 months | Source |
| Three-year share count growth | 123.8% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 52/10) Source
- Cash Runway
- 11 months Source
- Share Count Growth (3-Year)
- 123.8% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.